NCT00327769 - Faslodex Advanced Breast Cancer Local Chinese Study | Biotech Hunter

Enrollment

234

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

September 30, 2007

Conditions

Advanced Breast Cancer

Interventions

DRUG

Fulvestrant

250 mg intramuscular injection

DRUG

Anastrozole

1 mg tablet

Trial Locations (12)

Research Site, Beijing

Research Site, Dalian

Research Site, Fuzhou

Research Site, Guangzhou

Research Site, Hankou

Research Site, Hefei

Research Site, Huangzhou

Research Site, Jinan

Research Site, Nanjing

Research Site, Shanghai

Research Site, Wuhan

Research Site, Xi'an